Medtronic :: Modular, Portable & Versatile Soft-Tissue Robotic System

Medtronic is a global leader in healthcare technology and medical devices, headquartered in Ireland with principal U.S. operations in Minneapolis, Minnesota. Founded in 1949, the company employs over 95,000 people worldwide and focuses on developing therapies and solutions for chronic diseases, including cardiovascular, diabetes, neurological, and surgical conditions. In recent years, Medtronic has made significant investments in robotic-assisted surgery (RAS) as part of its broader push into minimally invasive and digital surgery.

The company’s flagship robotic platform is the Hugo™ Robotic-Assisted Surgery (RAS) System, a modular, portable, and versatile soft-tissue robotic system designed to expand access to robotic-assisted procedures. Unlike traditional fixed robotic systems, Hugo features independent, portable robotic arm carts that can be configured flexibly for different procedures and operating rooms (ORs). This modularity allows surgeons to use only the arms needed, potentially improving OR efficiency and reducing setup time.

Key features of the Hugo RAS System include:

• Modular arm carts with 3D visualization and instrument control
• Open console design for improved ergonomics and team collaboration
• Integration with the Touch Surgery™ Ecosystem for digital planning, training, and analytics
• AI-enhanced capabilities for procedure planning and performance insights
• Support for urologic, gynecologic, and general surgery procedures (with ongoing expansion)

The system received FDA clearance for urologic surgical procedures in late 2025, marking its formal entry into the U.S. market. It is already commercially available in more than 35 countries. Medtronic positions Hugo as a more accessible and cost-effective alternative to existing robotic systems, aiming to bring the benefits of minimally invasive robotic surgery to more patients and hospitals.

Beyond Hugo, Medtronic continues to invest in robotic technologies for neurosurgery, spinal surgery, and other specialties through acquisitions and internal development. The company’s robotics strategy is closely tied to its goal of creating a fully connected, intelligent operating room of the future.